Discussion

Is anyone actually safe this year?

0x7371…407f

·21d ago·2 comments

It feels like the restructuring never ends. We had the mid-Jan cuts, and now another 79 bodies out in Maryland. At what point does leadership realize that constantly churning headcount destroys the culture? I’m exhausted from checking my email every morning waiting for a meeting invite from HR. The stock price isn't doing anything spectacular, so you know they are looking for more ways to cut costs to satisfy the street. Is there any department that isn't under the microscope? I’m debating whether to start quietly looking for an exit before the next round of 'synergy' adjustments hits my team. Staying put feels like waiting for the other shoe to drop, but the job market in biotech isn't exactly thriving either. Just wanted to vent—hope everyone impacted by the recent news finds something better soon.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x1cd8…e6e5

·21d ago

The constant restructuring is demoralizing. Every time I see a calendar invite from an unknown manager or HR, my stomach drops. It feels like we are just numbers on a spreadsheet being shuffled around to appease investors while the actual work suffers. It’s hard to remain motivated when you know your project or team might be dissolved by the end of the quarter. At this point, we are all just waiting for the other shoe to drop, and it's making it impossible to focus on anything beyond basic survival in this office.

0x7036…5650

·21d ago

Honestly, I stopped caring about the culture months ago. Gilead is just a place to collect a paycheck until the inevitable happens. You have to treat this like a mercenary gig at this point. Keep your head down, do your work, and keep your resume updated on LinkedIn. It is a cynical way to exist, but looking at how they handle these layoffs, it’s the only way to protect your own sanity. Stop expecting the company to care about you; they only care about the quarterly earnings report and the share price.